Journal

Platelet-rich plasma dangers: risks and contraindications

Platelet-rich plasma dangers are low but real. Learn its contraindications, what the physician reviews beforehand, and when it is not indicated.

Longevia MedicalOctober 25, 2026Leer en español

Platelet-rich plasma: low risk, not zero risk

The dangers of platelet-rich plasma are not the same as those of a synthetic drug or a foreign-material implant. The procedure uses the patient's own blood, which eliminates the risk of immunological rejection. That is a genuine advantage. But eliminating that risk is not the same as eliminating all risks, and that distinction matters before making a decision.

What follows is an honest clinical description: which reactions are expected, which are warning signs, what the physician reviews before indicating the procedure, and in which cases it is not performed.

Expected reactions: what is part of the normal process

After a platelet-rich plasma session, the treated area may show inflammation, redness, and tenderness to the touch. These reactions are part of the biological response the procedure is designed to activate: the concentration of platelets releases growth factors that initiate a tissue repair process. Local discomfort is, in that sense, part of the mechanism.

A bruise at the injection site is also possible, particularly in highly vascularized areas or when the patient's clotting is slower than usual. It does not indicate that something went wrong, but it should be mentioned to the physician if it spreads or takes longer to resolve than the clinical team anticipates.

Local pain in the hours following application is common in articular areas. In applications on the skin or scalp it tends to be milder. Intensity varies according to the area, the technique, and each person's individual tolerance.

Local inflammation after a session is not an error: it is the signal that the tissue is responding. Clinical judgment lies in distinguishing when that response is expected and when it requires attention.

Platelet-rich plasma risks: infrequent but relevant

The more serious platelet-rich plasma risks are uncommon, but they exist and deserve a precise description. The first is infection. Although plasma preparation is carried out under controlled sterile conditions, any procedure that breaks the skin represents a potential entry point for microorganisms. Infection at the application site presents with warmth, progressive redness, discharge, and fever: when those signs appear, the person should seek medical attention that same day, not wait.

A second infrequent risk is nerve or vascular injury from injection into the wrong area. This risk depends directly on the technique and the experience of the physician performing the procedure. It is not a risk inherent to the plasma itself, but to the application.

In facial applications, particularly near medium-caliber vessels, there is a risk described in the general medical literature: accidental intravascular injection. If, after an application in that area, the person notices sudden changes in vision, skin turning white or violet, intense pain, or difficulty breathing, they must go to the emergency department immediately. This is not a situation for messages or calls to the clinic: it is a medical emergency.

Platelet-rich plasma is not a high-risk procedure. But no medical procedure carries zero risk, and that honesty is the basis of a responsible indication.

Platelet-rich plasma contraindications: what the physician reviews beforehand

Platelet-rich plasma contraindications are divided into absolute and relative. Absolute contraindications mean the procedure is not performed. Relative contraindications require a more detailed evaluation to determine whether it applies, under what conditions, and with what adjustments.

Absolute contraindications

  • Active infection in the area to be treated. Injecting into infected tissue can spread the infectious process. No clinical criterion justifies it.
  • Thrombocytopenia or platelet disorders. If the platelet count is low or platelet function is impaired, the concentration obtained will not produce the intended effect. The physician reviews this with prior bloodwork.
  • Active cancer or ongoing oncological treatment. The growth factors released by plasma stimulate cell proliferation, which represents a real risk in the presence of active oncological disease.
  • Severe uncontrolled coagulation disorders. Blood draw and subsequent injection require the coagulation system to function within safe parameters.

Medications the physician reviews beforehand

Certain medications that affect coagulation modify the response to the procedure or increase the risk of significant bruising. The physician asks about anticoagulants, antiplatelet agents, and non-steroidal anti-inflammatory drugs before the session. The decision to proceed, adjust, or postpone depends on an individual evaluation, not a universal rule. Decisions about medications are never made without direct medical supervision.

Situations that require more careful evaluation

  • Anaemia with low haemoglobin: affects the quality of the plasma obtained.
  • Autoimmune diseases in an active phase: the inflammatory response may be unpredictable.
  • Poorly controlled diabetes: wound healing and tissue response are impaired.
  • History of keloids or abnormal scarring in the area to be treated.
flowchart TD
    A["Platelet-rich plasma request"] --> B["Prior clinical evaluation and bloodwork"]
    B --> C{"Absolute contraindication\npresent?"}
    C -->|"Yes"| D["Procedure not indicated:\nother options explored"]
    C -->|"No"| E{"Relative contraindication\npresent?"}
    E -->|"Yes"| F["Protocol adjustment\nor postponement"]
    E -->|"No"| G["Indication confirmed:\nwritten plan issued"]
    G --> H["Session with medical supervision"]
    H --> I["Follow-up: response,\nreactions, progress"]

When platelet-rich plasma is not the right indication

Beyond formal contraindications, there are situations in which platelet-rich plasma is simply not the right tool for the objective the person is seeking. Not every case of hair loss, not every articular injury, and not every loss of facial volume has its best answer in plasma. Recognising that limit is part of the clinical work.

The available evidence supports the use of plasma in certain types of alopecia, in tendon injuries, and in tissue regeneration with specific indications. In other conditions, the data remain under investigation: there are preliminary results that justify further study, but there is not yet sufficient evidence to state that it works. In those cases, the clinical team says so with that same clarity.

Platelet-rich plasma is also not a substitute for a structural intervention when the condition requires one. A joint with severe damage may need a different approach before or instead of plasma. A scalp with extensive scarring may be beyond the procedure's reach. That conversation is part of the evaluation.

Platelet-rich plasma dangers: what depends on the procedure and what depends on the patient

The dangers of platelet-rich plasma are not all equivalent, nor do they share the same origin. Some depend on the patient's prior health status: platelet count, current medication, presence of infection or systemic disease. Others depend on the procedure itself: sterility, application technique, anatomical knowledge of the area.

A prior clinical evaluation exists precisely to separate both categories. The physician reviews the bloodwork, asks about history and medications, assesses the area to be treated, and determines whether the indication is appropriate. If it is, the plan is issued in writing with the number of sessions, measurable objectives, and follow-up. If it is not, that is stated with equal clarity.

Follow-up after each session is not an administrative formality. It is how the clinical team detects unexpected responses, adjusts the protocol, and decides whether to continue, modify, or stop the series. Without follow-up, part of the clinical judgment is lost.

The safety of platelet-rich plasma does not rest on it being "natural": it rests on the indication being correct, the technique being precise, and the follow-up being real.

Signs that require immediate medical attention

Some reactions after a session are not expected discomfort: they are signs of a complication that requires emergency care. The person must go to the emergency department immediately, without waiting until the next day or sending messages to the clinic, if any of the following symptoms appear:

  • Sudden changes in vision after an application in the facial area.
  • Skin turning white or violet in or around the treated area.
  • Intense and progressive pain that does not respond to standard measures.
  • Difficulty breathing or chest pain at any point after the procedure.
  • Fever with redness or discharge at the application site.
  • New neurological symptoms: numbness, weakness, or altered speech.

None of these situations is common. But naming them precisely is part of responsible clinical communication.

Frequently asked questions about platelet-rich plasma dangers

Can platelet-rich plasma cause an infection?

It is possible, though uncommon. Any procedure that breaks the skin represents a potential entry point for microorganisms. Sterility during preparation and application reduces that risk significantly. If progressive redness, warmth, or fever appears after the session, medical attention should be sought that same day.

Who cannot receive platelet-rich plasma?

Individuals with an active infection in the area to be treated, platelet disorders, active cancer or ongoing oncological treatment, or severe uncontrolled coagulation disorders have an absolute contraindication. Other conditions require individual evaluation before a decision is made.

Do anticoagulant medications prevent the treatment?

Not necessarily, but they do modify the clinical evaluation. The physician reviews each case before the session and may decide to adjust the protocol, postpone the procedure, or in certain cases not indicate it at all. Decisions about medications are always made by the physician, never by the patient independently.

Is bruising after the injection normal?

A localised bruise at the injection site is possible and does not indicate that something went wrong. It occurs more often in highly vascularised areas or when clotting is slower. If the bruise spreads, grows over time, or is accompanied by other symptoms, the treating physician should be informed.

Does platelet-rich plasma work for any type of injury or condition?

No. The evidence supports its use in specific indications. In other conditions the data remain under investigation. Part of the clinical work during the evaluation is determining whether plasma is the right tool for each person's specific objective, or whether another intervention better addresses that need.

For those who wish to review general information on medical procedures and health, Mayo Clinic and MedlinePlus are general reference resources for patients.

At Longevia Medical, in Puerto Cancún, care begins with an evaluation, in person or remote. If platelet-rich plasma is an appropriate indication for what you are seeking, the plan is issued in writing with the protocol, number of sessions, and follow-up. If it is not, that is stated with equal clarity. Request a private consultation or a remote evaluation to begin from that point.

Begin privately

Tell us what you want to protect.

This first conversation is for orientation, not diagnosis. A coordinator will identify the right clinical pathway and explain the secure next step.

Request a private consultation↗

Book a private consultation

Tell us what you want to protect.

Choose a preferred date and time. A coordinator confirms your appointment by WhatsApp or email and explains the secure next step. This first conversation is for orientation, not diagnosis.

Do not include medical records or sensitive health information here.
Thank you. We received your request. A coordinator will confirm your appointment by WhatsApp or email.